4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-044630
SVP and General Counsel sold 4,167 shares at an average $41.42 ($172,614)
- SVP and General Counsel acquired 4,167 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Taylor Stacy L · SVP and General Counsel
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-06-30 | Exercise or conversion : show line 1 in the form | +1,042 | $7.80 | $8,128 | 16,078 | D |
| 2021-06-30 | Exercise or conversion : show line 2 in the form | +1,771 | $6.55 | $11,600 | 17,849 | D |
| 2021-06-30 | Exercise or conversion : show line 3 in the form | +1,354 | $31.71 | $42,935 | 19,203 | D |
| 2021-06-30 | Sale : show line 4 in the form | −3,772 | $41.35 | $155,972 | 15,431 | D |
| 2021-06-30 | Sale : show line 5 in the form | −395 | $42.13 | $16,641 | 15,036 | D |
| Open-market sales · 4,167 sh · avg $41.42 · $172,614 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-30 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −1,042 | 22,917 | D |
| 2021-06-30 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −1,771 | 15,938 | D |
| 2021-06-30 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −1,354 | 43,334 | D |
Loading xslF345X03/doc4.xml…